221 related articles for article (PubMed ID: 26090754)
21. Plasma levels of sRANKL and OPG are associated with atherogenic cytokines in patients with intermediate cardiovascular risk.
Raaz-Schrauder D; Schrauder MG; Stumpf C; Lewczuk P; Kilian T; Dietel B; Garlichs CD; Schlundt C; Achenbach S; Klinghammer L
Heart Vessels; 2017 Nov; 32(11):1304-1313. PubMed ID: 28567553
[TBL] [Abstract][Full Text] [Related]
22. Elevated levels of monocyte activation markers are associated with subclinical atherosclerosis in men with and those without HIV infection.
McKibben RA; Margolick JB; Grinspoon S; Li X; Palella FJ; Kingsley LA; Witt MD; George RT; Jacobson LP; Budoff M; Tracy RP; Brown TT; Post WS
J Infect Dis; 2015 Apr; 211(8):1219-28. PubMed ID: 25362192
[TBL] [Abstract][Full Text] [Related]
23. Study of the osteoprotegerin/receptor activator of nuclear factor-kB ligand system association with inflammation and atherosclerosis in systemic sclerosis.
Gamal RM; Gamal WM; Ghandour AM; Abozaid HSM; Mohamed ME; Emad Y; Abdel Galeel A
Immunol Invest; 2018 Apr; 47(3):241-250. PubMed ID: 29336616
[TBL] [Abstract][Full Text] [Related]
24. Relation of osteoprotegerin to coronary calcium and aortic plaque (from the Dallas Heart Study).
Abedin M; Omland T; Ueland T; Khera A; Aukrust P; Murphy SA; Jain T; Gruntmanis U; McGuire DK; de Lemos JA
Am J Cardiol; 2007 Feb; 99(4):513-8. PubMed ID: 17293196
[TBL] [Abstract][Full Text] [Related]
25. Subclinical cardiovascular disease in HIV controller and long-term nonprogressor populations.
Brusca RM; Hanna DB; Wada NI; Blankson JN; Witt MD; Jacobson LP; Kingsley L; Palella FJ; Budoff M; Brown TT; Anastos K; Lazar JM; Mack WJ; Bacchetti P; Tien PC; Golzar Y; Plankey M; Golub E; Kaplan RC; Post WS
HIV Med; 2020 Apr; 21(4):217-227. PubMed ID: 31729142
[TBL] [Abstract][Full Text] [Related]
26. Brief Report: Changes in Plasma RANKL-Osteoprotegerin in a Prospective, Randomized Clinical Trial of Initial Antiviral Therapy: A5260s.
Kelesidis T; Moser CB; Johnston E; Stein JH; Dube MP; Yang OO; McComsey GA; Currier JS; Brown TT
J Acquir Immune Defic Syndr; 2018 Jul; 78(3):362-366. PubMed ID: 29533303
[TBL] [Abstract][Full Text] [Related]
27. Osteoprotegerin and RANKL serum concentrations in neonates of mothers with early-onset pre-eclampsia: comparison with neonates of normotensive mothers.
Oikonomou N; Papadopoulou C; Fouzas S; Kritikou D; Chrysis D; Sinopidis X; Dimitriou G; Karatza AA
Early Hum Dev; 2019 Aug; 135():1-5. PubMed ID: 31176082
[TBL] [Abstract][Full Text] [Related]
28. Associations between Tobacco, Alcohol, and Drug Use with Coronary Artery Plaque among HIV-Infected and Uninfected Men in the Multicenter AIDS Cohort Study.
Kelly SG; Plankey M; Post WS; Li X; Stall R; Jacobson LP; Witt MD; Kingsley L; Cox C; Budoff M; Palella FJ
PLoS One; 2016; 11(1):e0147822. PubMed ID: 26811937
[TBL] [Abstract][Full Text] [Related]
29. Glomerular filtration rate and proteinuria associations with coronary artery calcium among HIV-infected and HIV-uninfected men in the Multicenter AIDS Cohort Study.
Roy SK; Estrella MM; Darilay AT; Budoff MJ; Jacobson LP; Witt MD; Kingsley LA; Post WS; Palella FJ
Coron Artery Dis; 2017 Jan; 28(1):17-22. PubMed ID: 27611875
[TBL] [Abstract][Full Text] [Related]
30. Correlation of plasma osteoprotegerin (OPG) and receptor activator of the nuclear factor κB ligand (RANKL) levels with clinical risk factors in patients with advanced carotid atherosclerosis.
Giaginis C; Papadopouli A; Zira A; Katsargyris A; Klonaris C; Theocharis S
Med Sci Monit; 2012 Oct; 18(10):CR597-604. PubMed ID: 23018352
[TBL] [Abstract][Full Text] [Related]
31. Plasma monocyte chemoattractant protein-1 and tumor necrosis factor-α levels predict the presence of coronary artery calcium in HIV-infected individuals independent of traditional cardiovascular risk factors.
Shikuma CM; Barbour JD; Ndhlovu LC; Keating SM; Norris PJ; Budoff M; Parikh N; Seto T; Gangcuangco LM; Ogata-Arakaki D; Chow D
AIDS Res Hum Retroviruses; 2014 Feb; 30(2):142-6. PubMed ID: 23984974
[TBL] [Abstract][Full Text] [Related]
32. Subclinical myocyte injury, fibrosis and strain in relationship to coronary plaque in asymptomatic HIV-infected individuals.
Fitch KV; DeFilippi C; Christenson R; Srinivasa S; Lee H; Lo J; Lu MT; Wong K; Petrow E; Sanchez L; Looby SE; Hoffmann U; Zanni M; Grinspoon SK
AIDS; 2016 Sep; 30(14):2205-14. PubMed ID: 27314177
[TBL] [Abstract][Full Text] [Related]
33. Activation of the receptor activator of the nuclear factor-κB ligand pathway during coronary bypass surgery: comparison between on- and off-pump coronary artery bypass surgery procedures.
Galeone A; Brunetti G; Rotunno C; Oranger A; Colucci S; de Luca Tupputi Schinosa L; Zallone A; Grano M; Paparella D
Eur J Cardiothorac Surg; 2013 Aug; 44(2):e141-7. PubMed ID: 23671202
[TBL] [Abstract][Full Text] [Related]
34. Comparison of Insulin Resistance to Coronary Atherosclerosis in Human Immunodeficiency Virus Infected and Uninfected Men (from the Multicenter AIDS Cohort Study).
Brener MI; Post WS; Haberlen SA; Zhang L; Palella FJ; Jacobson LP; Dobs AS; George RT; Witt MD; Budoff M; Kingsley LA; Brown TT
Am J Cardiol; 2016 Mar; 117(6):993-1000. PubMed ID: 26830260
[TBL] [Abstract][Full Text] [Related]
35. Circulating osteoprotegerin and soluble RANK ligand in systemic sclerosis.
Dovio A; Data V; Carignola R; Calzolari G; Vitetta R; Ventura M; Saba L; Severino A; Angeli A
J Rheumatol; 2008 Nov; 35(11):2206-13. PubMed ID: 18843778
[TBL] [Abstract][Full Text] [Related]
36. Circulating levels of osteoprotegerin and receptor activator of NF-kappaB ligand in patients with chronic renal failure.
Shaarawy M; Fathy SA; Mehany NL; Hindy OW
Clin Chem Lab Med; 2007; 45(11):1498-503. PubMed ID: 17970704
[TBL] [Abstract][Full Text] [Related]
37. OPG/RANK/RANKL signaling axis in patients with type I diabetes: Associations with parathormone and vitamin D.
Karalazou P; Ntelios D; Chatzopoulou F; Fragou A; Taousani M; Mouzaki K; Galli-Tsinopoulou A; Kouidou S; Tzimagiorgis G
Ital J Pediatr; 2019 Dec; 45(1):161. PubMed ID: 31823791
[TBL] [Abstract][Full Text] [Related]
38. Comparison of racial differences in plaque composition and stenosis between HIV-positive and HIV-negative men from the Multicenter AIDS Cohort Study.
Miller PE; Budoff M; Zikusoka M; Li X; Palella F; Kingsley LA; Witt MD; Sharrett AR; Jacobson LP; Post WS
Am J Cardiol; 2014 Aug; 114(3):369-75. PubMed ID: 24929623
[TBL] [Abstract][Full Text] [Related]
39. Values of osteoprotegerin in aortic valve tissue in patients with significant aortic stenosis depend on the existence of concomitant coronary artery disease.
Fojt R; Pirk J; Kamenický P; Karpíšek M; Straka Z; Malý M; Moťovská Z
Cardiovasc Pathol; 2016; 25(3):181-184. PubMed ID: 26874038
[TBL] [Abstract][Full Text] [Related]
40. Low free testosterone in HIV-infected men is not associated with subclinical cardiovascular disease.
Monroe AK; Dobs AS; Xu X; Palella FJ; Kingsley LA; Post WS; Witt MD; Brown TT
HIV Med; 2012 Jul; 13(6):358-66. PubMed ID: 22296297
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
